Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01855529Phase 2Completed
Phase 2, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Centre Jean Perrin. Primary endpoint: Daily consumption of morphine at 48 hours. Started Apr 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01855529.